Mid-Sized Pharmas Mostly Seeing Valuations Rise During Pandemic

 
• By Joseph Haas
  
Conceptual image of increasing value of money shown by a coin from small to large number
Valuations rose for many mid-sized biopharmas during Q1 despite the ongoing pandemic

More from COVID-19

More from Scrip